1. This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More.

Aurobindo receives USFDA approval for fenofibrate tablets

Discussion in 'Stock Market Discussions' started by capitalstars05, May 6, 2016.

  1. capitalstars05

    capitalstars05 New Member

    Sep 26, 2014
    Likes Received:
    Aurobindo Pharma receives USFDA approval for fenofibrate tablets ( gTricor) – Positive for Aurobindo; Strong growth to sustain over next two years on the back of continuous product approvals being received.
    Aurobindo has received final approval from the USFDA to manufacture and market Fenofibrate Tablets, used to treat high level of cholesterol and triglyceride in the blood. This product is expected to be launched in Q1 FY16-17.

    Our Some Best Services Read it Here
    Domestic Forex Intraday,
    Financial Advisory Indore, Stock Advisory Indore,

    Commodity Market Tips, MCX Tips,

    Crude oil tips, Sgx Nifty,

    Nifty Futures Tips
    CapitalStars Financial Research Financial Advisory Services
    www.capitalstars.com | T:+91-731-6790000,6669900

Share This Page